James E Udelson MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation, Nuclear Cardiology
Professor, Medicine, Tufts Medical Center
Join to View Full Profile
750 Washington StNew England Medical CTRBoston, MA 02111
Phone+1 617-636-8066
Dr. Udelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Cardiovascular Disease, 1987 - 1989
Newton-Wellesley HospitalResidency, Internal Medicine, 1981 - 1984
New York Medical CollegeClass of 1981
Certifications & Licensure
MA State Medical License 1983 - 2025
MD State Medical License 1986 - 1987
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2010-2013
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium. Start of enrollment: 2006 Nov 01
- Heart Muscle Viability and Remodeling in Individuals Post-Heart Attack Start of enrollment: 2004 Jan 01
- Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg Start of enrollment: 2005 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- What Counts for Worsening Heart Failure Events.Gregg C Fonarow, Adrian F Hernandez, James E Udelson, Clyde W Yancy
JAMA Cardiology. 2025-02-26 - Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial.Clara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, Aiwen Xing, Davis Gates
European Journal of Heart Failure. 2025-02-16 - 3 citationsVericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial.Yogesh N V Reddy, Javed Butler, Kevin J Anstrom, Robert O Blaustein, Marc P Bonaca
European Journal of Heart Failure. 2025-02-01
Journal Articles
- Return to Play for Athletes After Coronavirus Disease 2019 Infection—Making High-Stakes Recommendations as Data EvolveJames E Udelson, Ethan J Rowin, JAMA Cardiology
- Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients with Heart Failure with Preserved Ejection FractionJames E Udelson, Margaret M Redfield, Marvin A Konstam, JAMA
- State-of-the-Art Paper Heart Failure with Improved Ejection Fraction: Is It Possible to Escape One’s Past?James E Udelson, Gaurav Gulati, ScienceDirect
- Join now to see all
Lectures
- It's All About Me: Individualizing Your Approach to Statin: Pharmacology Session II2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Imaging in the Management of Acute Chest PainAmerican Heart Association, Scientific Sessions 2008, New Orleans, Louisiana, USA
- Imaging in the Management of Acute Chest PainScientific Sessions 2008, New Orleans, Louisiana, USA
Other
- Imaging Coronary Anatomy and Reducing Myocardial InfarctionJames Udelson, MD, The New England Journal of Medicine
https://www.doximity.com/articles/4ae452e8-fbee-4c02-826b-ab006063d400
UpToDate, Wolters Kluwer Health - 2012-08-29 - Tolerability of the scFurosemide Infusor in Patients with Heart FailureJames Udelson, MD, Journal of Cardiac Failure
https://www.doximity.com/articles/498ad2e8-a83c-4ee1-b2b3-c7e0139a4d1e
UpToDate, Wolters Kluwer Health - 2012-06-22
Authored Content
- Imaging Coronary Anatomy and Reducing Myocardial InfarctionAugust 2018
- Tolerability of the scFurosemide Infusor in Patients with Heart FailureAugust 2018
- Dual Vasopressin V1a/V2 Antagonism: The Next Step in Neurohormonal Modulation in Patients with Heart Failure?January 2018
- Dual Vasopressin V1a/V2 Antagonism: The Next Step in Neurohormonal Modulation in Patients with Heart Failure?January 2018
- Join now to see all
Press Mentions
Leading the Way: Inside New England’s Number 1 Heart Transplant ProgramFebruary 13th, 2025- Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCTFebruary 11th, 2025
- Taking Blood Pressure in Noisy Settings Doesn’t Affect Reading, Study ShowsJanuary 27th, 2025
- Join now to see all
Grant Support
- Myocardial Viability And Remodeling In The OATNational Heart, Lung, And Blood Institute2004–2008
- LV Function Assessment Core LAB For Immediate TrialNational Heart, Lung, And Blood Institute2004–2006
- Foreign Cohort: Myocardial Viability And Remodeling In The Oat-NucNational Heart, Lung, And Blood Institute2005
- Domestic Cohort: Myocardial Viability And Remodeling In The Oat-NucNational Heart, Lung, And Blood Institute2005
- Selective Estrogen Receptor Modulation: Effects In Post-Menopausal WomenNational Center For Research Resources2005
- Selective Estrogen Receptor Modulation: Effects In WomenNational Center For Research Resources2004
- Estrogen Receptor Modulation--Effects In Post Menopausal WomenNational Heart, Lung, And Blood Institute2000–2004
- Estrogen Receptor Modulation--Effects In Postmenopausal Women Following MyocardiaNational Center For Research Resources2000–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
